CD63 and cancer: Yet, overexpression of TIMP1 by various cancer types has been associated with increased disease severity and pro-metastatic effects (25), partly mediated by TIMP1/CD63/ITGB1 activation of focal adhesion kinase (FAK) signaling (46).